THEOPHYLLINE ER 300 MG TABLET

Theophylline
$0.3458per EA
Low Outlier

Strength

300 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135045790

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

THEOPHYLLINE ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA089763

On Market Since

6/27/2022

Pharmacological Classes

Price History

1W

0.0%

1M

-2.1%

3M

-19.7%

6M

-22.5%

1Y

-39.8%

3Y

-87.1%

5Y

N/A

All

-84.2%